Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
San Francisco Chronicle - Thursday, December 12, 2002
Teresa Castle, Chronicle Staff Writer
In Khayelitsha, a sprawling shantytown near Cape Town, the Nobel Peace Prize winning group Doctors Without Borders is treating 300 patients, all of whom are in the advanced stages of the disease.
The goal is to counter the government's claim that treatment is impossible -- and even dangerous, because of the possibility of developing resistance to ARV drugs -- without the sophisticated medical infrastructure and extensive blood testing common in the West. Patients are treated by nurses, not doctors, and their infection levels and immune response are tested only twice a year.
The results so far provide hope for a nation in need: 90 percent of the first group of patients had undetectable levels of HIV after three months of treatment.
A similar program is being carried out at Chris Hani Baragwanath Hospital in Soweto, where doctors are providing ARVs with the help of a $22 million grant from the National Institutes of Health. When the project is in full swing, it will be giving the drugs to 1,800 people in Soweto and the Cape Town area.
In collaboration with Pangaea, an affiliate of the San Francisco AIDS Foundation, the doctors in Soweto have applied for a $15 million Secure the Future grant from Bristol Myers Squibb to offer ARVs to another 2,100 patients.
Earlier this month, Nelson Mandela, who has served as a sort of conscience of the nation on the AIDS issue, raised the stakes even higher.
The Nelson Mandela Foundation and the South African Medical Association joined forces to announce the nation's largest program ever to provide anti- retroviral drugs. It is seeking $8 million in donations to provide free medicines to 9,000 patients at 18 sites across the country.
"Talk is necessary but it is not sufficient," Mandela said in introducing the program. "The test is what you are doing on the ground."
021212
SC021208
Copyright © 2002 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com. http://www.sfgate.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .